awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48194472-A24D60C7-4446-45A4-B4E5-5F63EA129CCB
Q48194472-A24D60C7-4446-45A4-B4E5-5F63EA129CCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194472-A24D60C7-4446-45A4-B4E5-5F63EA129CCB
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.
P2860
Q48194472-A24D60C7-4446-45A4-B4E5-5F63EA129CCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194472-A24D60C7-4446-45A4-B4E5-5F63EA129CCB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39083a6afc324a6ae9f8c85275df9e327b23a19c
P2860
Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer.